Stroke Management
Protocol
DR ANKIT GAJJAR
MD, IDCCM, EDIC
CONSULTANT INTENSIVIST
Why protocol-ize the stroke treatment?
• Stroke is the first leading cause of disability and 3rd leading
cause of mortality
• 1.44 – 1.64 mio cases of new acute stroke every year
• 0.63 mio deaths
• 63,98,000 DALYs lost due to stroke
Neurology Asia 2006; 11(1-4).
Stroke and its consequences in India are of
epidemic nature
However, treatment application is endemically
low
Background
• After publication of the results of the National Institute of
Neurological Disorders and Stroke (NINDS) study, the application of
intravenous thrombolysis for ischemic stroke was launched and
has now been in use for more than 17 years.
• This breakthrough ended decades of therapeutic nihilism but we
have to acknowledge the fact that despite recommendations, less
than 5-6% of potentially eligible patients are
currently being treated in India
Actilyse® • Emergency Physician Slide Kit
Pathophysiology of ischemic stroke and TIA
Gorelick. J Med 2009;2:1-8.
An ischaemic stroke is the result of a
vascular occlusion in the blood supply
to an area of the brain, which results in
cerebral ischemia lasting more than 60
min
Causes of ischemia
• Thrombotic
• Embolic
Potential to Reverse Neurologic Impairment With
Thrombolytic Reperfusion
Saver. Stroke 2006;37:263-266.
González. Am J Neuroradiol 2006;27:728-735.
Donnan. Lancet Neurol 2002;1:417-425.
An untreated patient loses
approximately 1.9 million
neurons every minute in the
ischemic area
Reperfusion offers the potential
to reduce the extent of ischemic
injury
Ischaemic core
(brain tissue
destined to die)
Penumbra
(salvageable
brain area)
Actilyse® • Emergency Physician Slide Kit
“Time is brain”
Saver. Stroke 2006;37:263-266.
Estimated Pace of Neural Circuitry Loss In Typical Large-Vessel Supratentorial Acute Ischaemic
Stroke
Neurons Lost Synapses Lost Myelinated Fibres Lost Accelerated Aging
Per Stroke 1.2 billion 8.3 trillion 7140 km 36 y
Per Hour 120 million 830 billion 714 km 3.6 y
Per Minute 1.9 million 14 billion 12 km 3.1 wk
Per Second 32,000 230 million 200 m 8.7 h
Minutes Hours Days
Inflammation
Peri-infarct
depolarisations
Excitotoxicity
Impact
Apoptosis
Time
• The benefits of only approved drug for acute ischemic stroke are
highly time dependant and therefore it is imperative
to develop a system to minimize the delays in
administration of alteplase
• Hence the protocol-ization
Stroke Chain of Survival
DETECTION DISPATCH DELIVERY DOOR DATA DECISION DRUG DISPOSITION
Pre-Hospital Emergency Department
8 D’s of Stroke Chain of Survival
• At risk population
• Symptoms
PATIENT
• Family members
• Colleagues
COMMUNITY
• Family physicians/GP
• EMS
HEALTH CARE
PROVIDERS
DETECTION
• Call Handlers awareness
• Stroke alert displaysSUSPICION
• Same as heart attack/trauma
• Rapid dispatch/alerts
HIGHEST
PRIORITY
• A,B,C
• Symptoms
• Exact time of onset
• Blood Sugar
• CINCINNATI STROKE SCALE
• DO NOT REDUCE THE BP
ON SCENE
CARE
DISPATCH
• A,B,C, care
• Flat or 30 degree elevation
• Oxygen ,IV access, Monitor
• Draw and keep blood samples
EN ROUTE
CARE
• NEAREST WITH MINIMUM FACILITY
NOT NECESSARILY THE BEST
• CT scan at least, neurophysician
availability
IDENTIFY
APPROPRIATE
CENTRE
• EXACT TIME OF ONSET
• GCS,GRBS
• RISK FACTORS
PRE ARRIVAL
NOTIFICATION
DELIVERY
Actilyse® • Emergency Physician Slide Kit
 Emergency services need to announce estimated time of arrival
and alert stroke team
 Bypass administrative admission
Stroke networks
Pre- and in-hospital team co-ordination
INTENSIVIST
Emergency physician
Neurologist
Stroke
Meeting
Point
Nurse
Radiologist
• Triage team alert
• Bed allocation, nurse allocation
RAPID &
HIGHEST TRIAGE
PRIORITY
• TIME SINCE ONSET
• ABCDE
• RULE OUT TRAUMA/FEVER
• BP, RBS, ECG
• RBS must precede IV rtPA
FOCUSSED
HISTORY &
ASSESSMENT
• GCS,NIHSS (Preferred)
• PUPILS
• Lateralising deficits
• Stroke profile, stroke team alert
SPECIFIC
NEUROLOGICAL
ASSEESMENT
INVESTIGATIONS
DOOR
• Worsening or Improving, status quo
• BP > or < 185/110
• Sugars
• Time since onset < or > 4.5 hrs
• INCLUSION/EXCLUSION CRITERIA
CLINICAL
• NECT(preferred) or MRI rule out ICH
• Bleed-inform Neurosurgery
• No bleed-Reassess patient, rule out
other causes
IMAGING
• Platelets, coagulation profile
• S. creatinine
LABS
DATA
• Time since onset < or > 4.5 hrsTIME SINCE
ONSET
• ALL YES
• INCLUDE FAMILY ALSO!!
INCLUSION
CRITERIA
• ALL NO
EXCLUSION
CRITERIA
DECISION
INCLUSION CRITERIA
• Diagnosis of ischemic stroke with mesurable
neurological deficit
• Onset of symptoms <3 hrs (selected cases
<4.5 hrs)
• Age > 18 yrs
Additional Inclusion and Exclusion Characteristics of Patients
With Acute Ischemic Stroke Who Could Be Treated With IV
rtPA Within 3 to 4.5 Hours From Symptom Onset
Jauch el al. Stroke. 2013 Mar;44(3):870-947
Actilyse® • Emergency Physician Slide Kit
Bock. NINDS Stroke symposium proceedings 1996; Updated 2011.
Door-to-MD 10 minutes
Door-to-Stroke
Team Notification
Door-to-CT Scan 25 minutes
Door-to-Needle
Door-to-Admission 3 hours
15 minutes
60 minutes
Emergency department response times
NINDS recommendations
Actilyse®
Hoylaerts et al. J Biol Chem1982;257:2912-2919.
Actilyse®, rt-PA (alteplase), is a serine protease, similar to
naturally occurring tissue plasminogen activator (t-PA)
Mode of action
With high affinity, Actilyse® binds to and activates
plasminogen attached to the fibrin netting of a blood clot
Plasminogen is converted to plasmin, which catalyses the
breakdown of fibrin to its degradation products, resulting in
break up of the clot
The affinity for freely circulating plasminogen is low, so
Actilyse® has highly effective local fibrinolytic effects and
relatively few systemic effects
• DOSE-0.9mg/kg -10% as bolus rest as
infusion over 60 mins (max 100 mg)
• ADMINISTRATION-continuous
• MONITORING- every 15 mins for 1st hour
tPA
• Labetalol-BP control only if >185/110
• No other anticoagulants/antiplatelet
agents
Other
drugs
• Foley’s, Ryle’s tube for first 24 hours
Avoid
procedures
DRUG
t-PA administration
• A powder vial and a solvent vial (sterile water for injection)
• Powder to be reconstituted with solvent and the resulting solution is
1mg/ml
• DON’T SHAKE the solution vigorously. Only gentle swirl is sufficient
• Body weight based total dose calculated and first 10% as a bolus
over 1-2 minutes and remaining as an infusion over 60 minutes
• TPA-UNINTERRUPTED
• MONITORING
CONTINUUM
OF CARE
• Pre arrival notification
• Protocol based care
• Trained staff
STROKE UNIT
DISPOSITION
ICU CARE
All of the above procedures to be finished in
less than an hr as per NIH recommendation
However, in today’s time even 1 hr seems
quite long
Actilyse® • Emergency Physician Slide Kit
NIH-recommended emergency department response
times
Bock. NINDS Stroke symposium proceedings 1996; Updated 2011.
DTN ≤60 min: the “golden hour” for evaluating and treating acute stroke
T=0
Suspected
stroke patient
arrives at
stroke unit
≤10 min
Initial physician
evaluation
(including patient
history, lab work
initiation, & NIHSS)
≤ 15 min
Stroke team
notified
(including
neurologic
expertise)
≤ 25 min
CT scan
initiated
≤ 45 min
CT & labs
interpreted
≤ 60 min
rt-PA
given if
patient
is eligible
IDEALLY
performed pre-hospital
Preparing the Patient for rt-PA in 30 min
(Optimally 15 min)
Vital parameters, sugar, INR 5min (3min)
History, Labs, call CT 3min (2min)
NIHSS 5min (2min)
CT (with rt-PA at hand)
To CT 5min (2min)
CT 5min (4min)
Reading 3min (1min)
ICH ?
Large and/or demarcated infarction ?
Measure / Estimate weight 1min (0min)
Prepare rt-PA, inject 3min (1min)
Personal communication, Peter Schellinger, Jan 2011.
NIHSS SCORE
A 60 year old diabetic hypertensive male presents to ER with
weakness of left arm and leg. He is conscious, alert and oriented
and denies any headache, vomiting or seizures. Clinical
examination is suggestive of a stroke. Most appropriate next step
in the management?
•Treat patient assuming that he has an ischemic stroke without
any neurological imaging as he has no symptoms of a
hemorrhagic stroke (such as headache and vomiting).
•Perform a plain CT scan of brain
•Request for MRI brain
•Give aspirin
• Went to sleep at 10 pm previous night
•Visited bathroom at 5:45 am, answered wife
•Woke up at 7 am with left arm weakness
•Comes to ER at 8:15 am
??Thrombolyse
• This patient has a BP 200/110 ; has suffered a MI 6
months ago; had a CABG 3 months ago, is on
Antiplatelets and also on warfarin for AF
• This patient is not eligible for thrombolysis because
• 1.BP is 200/110
• 2.CT Scan shows massive change
• 3. Had recent MI and CABG
• 4. Is on Antiplatelets and Warfarin
Can Thrombolysis Be Done ?
Protocol
• Patient came to emergency or activated EMS
• 1) Emergency RMO
 A,B,C
 Brief neurological examination
 History (time since onset and medication)
 Detail history (if candidate for thrombolysis) to rule
out contraindication
• 2) First nurse
 Oxygen if required
 RBS
 IV Cannula (2)
 Blood samples (PT/INR/ APTT , PLT , Creat)
 12 lead ECG
Protocol
• 2) Second Nurse (Telephonic Nurse)
 INTENSIVIST
 On call physician or Neurophysician
 CT SCAN (Radiologist)
 Pharmacy
Suspected Acute Ischemic Stroke
CT/MR
<4.5hrs >4.5hrs
IV tPA
Candidate?
Other Rx
Trials
Supportive
Care
CTA/CTP,MR
A,PWI-DWI
0.9 mg/kg
IV tPA
CTA,MRA
Large vessel
Clot?
Consider: IA lytics or
devices Off –label IV
tPA
Visible Clot or
Penumbra ?
• INFORMED CONSENT IS MUST
42
Summary
This is what should happen:
 Recognize the signs of stroke and TIA
 Rapid neuro exam (Cincinnati Stroke Scale or similar).
 Determine time of symptom onset (if possible).
 Provide rapid transport to an ED capable of caring for acute
stroke (pre-notify).
 Perform finger-stick to assess serum glucose levels.
43
Summary
• Failure to recognize signs and
symptoms of stroke/TIA
• Failure to attempt to determine
symptom onset.
– Delay in transport.
– Transporting a potential stroke patient
to an ED not capable of treating acute
ischemic stroke with fibrinolytic
therapy.
44
Summary: Pre-hospital UNACCEPTABLE Actions
• Attempts to treat hypertension in the
field.
• Failure to notify other departments
• DON’T GIVE ASPIRIN BEFORE CT
• DON’T WASTE TIME
THANK YOU…

Stroke thrombolysis protocol

  • 1.
    Stroke Management Protocol DR ANKITGAJJAR MD, IDCCM, EDIC CONSULTANT INTENSIVIST
  • 3.
    Why protocol-ize thestroke treatment? • Stroke is the first leading cause of disability and 3rd leading cause of mortality • 1.44 – 1.64 mio cases of new acute stroke every year • 0.63 mio deaths • 63,98,000 DALYs lost due to stroke Neurology Asia 2006; 11(1-4). Stroke and its consequences in India are of epidemic nature However, treatment application is endemically low
  • 4.
    Background • After publicationof the results of the National Institute of Neurological Disorders and Stroke (NINDS) study, the application of intravenous thrombolysis for ischemic stroke was launched and has now been in use for more than 17 years. • This breakthrough ended decades of therapeutic nihilism but we have to acknowledge the fact that despite recommendations, less than 5-6% of potentially eligible patients are currently being treated in India
  • 5.
    Actilyse® • EmergencyPhysician Slide Kit Pathophysiology of ischemic stroke and TIA Gorelick. J Med 2009;2:1-8. An ischaemic stroke is the result of a vascular occlusion in the blood supply to an area of the brain, which results in cerebral ischemia lasting more than 60 min Causes of ischemia • Thrombotic • Embolic
  • 6.
    Potential to ReverseNeurologic Impairment With Thrombolytic Reperfusion Saver. Stroke 2006;37:263-266. González. Am J Neuroradiol 2006;27:728-735. Donnan. Lancet Neurol 2002;1:417-425. An untreated patient loses approximately 1.9 million neurons every minute in the ischemic area Reperfusion offers the potential to reduce the extent of ischemic injury Ischaemic core (brain tissue destined to die) Penumbra (salvageable brain area)
  • 7.
    Actilyse® • EmergencyPhysician Slide Kit
  • 8.
    “Time is brain” Saver.Stroke 2006;37:263-266. Estimated Pace of Neural Circuitry Loss In Typical Large-Vessel Supratentorial Acute Ischaemic Stroke Neurons Lost Synapses Lost Myelinated Fibres Lost Accelerated Aging Per Stroke 1.2 billion 8.3 trillion 7140 km 36 y Per Hour 120 million 830 billion 714 km 3.6 y Per Minute 1.9 million 14 billion 12 km 3.1 wk Per Second 32,000 230 million 200 m 8.7 h Minutes Hours Days Inflammation Peri-infarct depolarisations Excitotoxicity Impact Apoptosis Time
  • 9.
    • The benefitsof only approved drug for acute ischemic stroke are highly time dependant and therefore it is imperative to develop a system to minimize the delays in administration of alteplase • Hence the protocol-ization
  • 10.
    Stroke Chain ofSurvival DETECTION DISPATCH DELIVERY DOOR DATA DECISION DRUG DISPOSITION Pre-Hospital Emergency Department 8 D’s of Stroke Chain of Survival
  • 11.
    • At riskpopulation • Symptoms PATIENT • Family members • Colleagues COMMUNITY • Family physicians/GP • EMS HEALTH CARE PROVIDERS DETECTION
  • 12.
    • Call Handlersawareness • Stroke alert displaysSUSPICION • Same as heart attack/trauma • Rapid dispatch/alerts HIGHEST PRIORITY • A,B,C • Symptoms • Exact time of onset • Blood Sugar • CINCINNATI STROKE SCALE • DO NOT REDUCE THE BP ON SCENE CARE DISPATCH
  • 13.
    • A,B,C, care •Flat or 30 degree elevation • Oxygen ,IV access, Monitor • Draw and keep blood samples EN ROUTE CARE • NEAREST WITH MINIMUM FACILITY NOT NECESSARILY THE BEST • CT scan at least, neurophysician availability IDENTIFY APPROPRIATE CENTRE • EXACT TIME OF ONSET • GCS,GRBS • RISK FACTORS PRE ARRIVAL NOTIFICATION DELIVERY
  • 14.
    Actilyse® • EmergencyPhysician Slide Kit  Emergency services need to announce estimated time of arrival and alert stroke team  Bypass administrative admission Stroke networks Pre- and in-hospital team co-ordination INTENSIVIST Emergency physician Neurologist Stroke Meeting Point Nurse Radiologist
  • 15.
    • Triage teamalert • Bed allocation, nurse allocation RAPID & HIGHEST TRIAGE PRIORITY • TIME SINCE ONSET • ABCDE • RULE OUT TRAUMA/FEVER • BP, RBS, ECG • RBS must precede IV rtPA FOCUSSED HISTORY & ASSESSMENT • GCS,NIHSS (Preferred) • PUPILS • Lateralising deficits • Stroke profile, stroke team alert SPECIFIC NEUROLOGICAL ASSEESMENT INVESTIGATIONS DOOR
  • 17.
    • Worsening orImproving, status quo • BP > or < 185/110 • Sugars • Time since onset < or > 4.5 hrs • INCLUSION/EXCLUSION CRITERIA CLINICAL • NECT(preferred) or MRI rule out ICH • Bleed-inform Neurosurgery • No bleed-Reassess patient, rule out other causes IMAGING • Platelets, coagulation profile • S. creatinine LABS DATA
  • 18.
    • Time sinceonset < or > 4.5 hrsTIME SINCE ONSET • ALL YES • INCLUDE FAMILY ALSO!! INCLUSION CRITERIA • ALL NO EXCLUSION CRITERIA DECISION
  • 19.
    INCLUSION CRITERIA • Diagnosisof ischemic stroke with mesurable neurological deficit • Onset of symptoms <3 hrs (selected cases <4.5 hrs) • Age > 18 yrs
  • 20.
    Additional Inclusion andExclusion Characteristics of Patients With Acute Ischemic Stroke Who Could Be Treated With IV rtPA Within 3 to 4.5 Hours From Symptom Onset Jauch el al. Stroke. 2013 Mar;44(3):870-947
  • 23.
    Actilyse® • EmergencyPhysician Slide Kit Bock. NINDS Stroke symposium proceedings 1996; Updated 2011. Door-to-MD 10 minutes Door-to-Stroke Team Notification Door-to-CT Scan 25 minutes Door-to-Needle Door-to-Admission 3 hours 15 minutes 60 minutes Emergency department response times NINDS recommendations
  • 24.
    Actilyse® Hoylaerts et al.J Biol Chem1982;257:2912-2919. Actilyse®, rt-PA (alteplase), is a serine protease, similar to naturally occurring tissue plasminogen activator (t-PA) Mode of action With high affinity, Actilyse® binds to and activates plasminogen attached to the fibrin netting of a blood clot Plasminogen is converted to plasmin, which catalyses the breakdown of fibrin to its degradation products, resulting in break up of the clot The affinity for freely circulating plasminogen is low, so Actilyse® has highly effective local fibrinolytic effects and relatively few systemic effects
  • 25.
    • DOSE-0.9mg/kg -10%as bolus rest as infusion over 60 mins (max 100 mg) • ADMINISTRATION-continuous • MONITORING- every 15 mins for 1st hour tPA • Labetalol-BP control only if >185/110 • No other anticoagulants/antiplatelet agents Other drugs • Foley’s, Ryle’s tube for first 24 hours Avoid procedures DRUG
  • 26.
    t-PA administration • Apowder vial and a solvent vial (sterile water for injection) • Powder to be reconstituted with solvent and the resulting solution is 1mg/ml • DON’T SHAKE the solution vigorously. Only gentle swirl is sufficient • Body weight based total dose calculated and first 10% as a bolus over 1-2 minutes and remaining as an infusion over 60 minutes
  • 27.
    • TPA-UNINTERRUPTED • MONITORING CONTINUUM OFCARE • Pre arrival notification • Protocol based care • Trained staff STROKE UNIT DISPOSITION
  • 28.
  • 29.
    All of theabove procedures to be finished in less than an hr as per NIH recommendation However, in today’s time even 1 hr seems quite long
  • 30.
    Actilyse® • EmergencyPhysician Slide Kit NIH-recommended emergency department response times Bock. NINDS Stroke symposium proceedings 1996; Updated 2011. DTN ≤60 min: the “golden hour” for evaluating and treating acute stroke T=0 Suspected stroke patient arrives at stroke unit ≤10 min Initial physician evaluation (including patient history, lab work initiation, & NIHSS) ≤ 15 min Stroke team notified (including neurologic expertise) ≤ 25 min CT scan initiated ≤ 45 min CT & labs interpreted ≤ 60 min rt-PA given if patient is eligible IDEALLY performed pre-hospital
  • 31.
    Preparing the Patientfor rt-PA in 30 min (Optimally 15 min) Vital parameters, sugar, INR 5min (3min) History, Labs, call CT 3min (2min) NIHSS 5min (2min) CT (with rt-PA at hand) To CT 5min (2min) CT 5min (4min) Reading 3min (1min) ICH ? Large and/or demarcated infarction ? Measure / Estimate weight 1min (0min) Prepare rt-PA, inject 3min (1min) Personal communication, Peter Schellinger, Jan 2011.
  • 32.
  • 34.
    A 60 yearold diabetic hypertensive male presents to ER with weakness of left arm and leg. He is conscious, alert and oriented and denies any headache, vomiting or seizures. Clinical examination is suggestive of a stroke. Most appropriate next step in the management? •Treat patient assuming that he has an ischemic stroke without any neurological imaging as he has no symptoms of a hemorrhagic stroke (such as headache and vomiting). •Perform a plain CT scan of brain •Request for MRI brain •Give aspirin
  • 35.
    • Went tosleep at 10 pm previous night •Visited bathroom at 5:45 am, answered wife •Woke up at 7 am with left arm weakness •Comes to ER at 8:15 am ??Thrombolyse
  • 36.
    • This patienthas a BP 200/110 ; has suffered a MI 6 months ago; had a CABG 3 months ago, is on Antiplatelets and also on warfarin for AF • This patient is not eligible for thrombolysis because • 1.BP is 200/110 • 2.CT Scan shows massive change • 3. Had recent MI and CABG • 4. Is on Antiplatelets and Warfarin Can Thrombolysis Be Done ?
  • 37.
    Protocol • Patient cameto emergency or activated EMS • 1) Emergency RMO  A,B,C  Brief neurological examination  History (time since onset and medication)  Detail history (if candidate for thrombolysis) to rule out contraindication
  • 38.
    • 2) Firstnurse  Oxygen if required  RBS  IV Cannula (2)  Blood samples (PT/INR/ APTT , PLT , Creat)  12 lead ECG
  • 39.
    Protocol • 2) SecondNurse (Telephonic Nurse)  INTENSIVIST  On call physician or Neurophysician  CT SCAN (Radiologist)  Pharmacy
  • 40.
    Suspected Acute IschemicStroke CT/MR <4.5hrs >4.5hrs IV tPA Candidate? Other Rx Trials Supportive Care CTA/CTP,MR A,PWI-DWI 0.9 mg/kg IV tPA CTA,MRA Large vessel Clot? Consider: IA lytics or devices Off –label IV tPA Visible Clot or Penumbra ?
  • 41.
  • 42.
    42 Summary This is whatshould happen:  Recognize the signs of stroke and TIA  Rapid neuro exam (Cincinnati Stroke Scale or similar).  Determine time of symptom onset (if possible).  Provide rapid transport to an ED capable of caring for acute stroke (pre-notify).  Perform finger-stick to assess serum glucose levels.
  • 43.
    43 Summary • Failure torecognize signs and symptoms of stroke/TIA • Failure to attempt to determine symptom onset. – Delay in transport. – Transporting a potential stroke patient to an ED not capable of treating acute ischemic stroke with fibrinolytic therapy.
  • 44.
    44 Summary: Pre-hospital UNACCEPTABLEActions • Attempts to treat hypertension in the field. • Failure to notify other departments • DON’T GIVE ASPIRIN BEFORE CT • DON’T WASTE TIME
  • 45.